Experimental Induction of SLE by Altered Ia

改变 Ia 诱导 SLE 的实验

基本信息

  • 批准号:
    6789950
  • 负责人:
  • 金额:
    $ 29.8万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1984
  • 资助国家:
    美国
  • 起止时间:
    1984-07-01 至 2007-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The autoimmune chronic graft-versus-host (cGVH) reaction in mice is a powerful model to investigate the mechanisms of loss of B-cell tolerance and the mechanisms whereby failure of such tolerance can lead to systemic autoimmunity characteristic of systemic lupus erythematosus (SLE). 1) Hypothesis: Different mechanisms of tolerance are important in regulating the anti-dsDNA response resulting from different Ig transgenes, cGVH will be induced in a series of immunoglobulin site-directed (knockin) transgenic mouse strains. 1) Hypothesis: The loss of tolerance in B cells in the cGVH model of SLE is accompanied by changes in gene expression that can be documented at the RNA level. Such genes and their protein products will be attractive targets for quantifying disease activity, understanding the molecular mechanisms that underlie the loss of B-cell tolerance and intervening therapeutically. 1) Hypothesis: The loss of tolerance in B cells in the cGVH model of SLE occurs because of the interaction of abnormal (allo-) T-cell help with B cells at discrete developmental stages. Transgenic B cells will be purified by surface markers of ontogeny and transferred in an adoptive cGVH system. 1) Hypothesis: The loss of tolerance in B cells in the cGVH model of SLE occurs in a small subpopulation, even in recipient mice with a highly skewed B-cell repertoire. This implies further failures of tolerance checkpoints, perhaps on a stochastic basis, that needs to be elucidated. 1) Hypothesis: Specific T cells from the recipient are critical for the cGVH autoimmune reaction. CD4 T cells permit autoreactive B cells to become receptive to allohelp by mechanisms to be explored. These studies will elucidate how a B cell with specificity for an important lupus specific antigen (dsDNA) can lose tolerance and become autoreactive. Since this process of tolerance loss is central to the pathogenesis of SLE, the results will help clarify some of the fundamental underlying mechanisms of this disease.
描述(由申请人提供):小鼠自身免疫性慢性移植物抗宿主(cGVH)反应是一个强大的模型,可以研究b细胞耐受性丧失的机制,以及这种耐受性失败导致系统性红斑狼疮(SLE)系统性自身免疫特征的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROBERT A. EISENBERG其他文献

ROBERT A. EISENBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROBERT A. EISENBERG', 18)}}的其他基金

Mechanisms of anti B cell therapy in SLE
SLE 抗 B 细胞治疗的机制
  • 批准号:
    6354592
  • 财政年份:
    2000
  • 资助金额:
    $ 29.8万
  • 项目类别:
Mechanisms of anti B cell therapy in SLE
SLE 抗 B 细胞治疗的机制
  • 批准号:
    6228084
  • 财政年份:
    1999
  • 资助金额:
    $ 29.8万
  • 项目类别:
EXPERIMENTAL INDUCTION OF SLE BY ALTERED IA
通过改变 IA 实验诱导 SLE
  • 批准号:
    2078964
  • 财政年份:
    1994
  • 资助金额:
    $ 29.8万
  • 项目类别:
SCOR IN SYSTEMIC LUPUS ERYTHEMATOSUS
系统性红斑狼疮的 SCOR
  • 批准号:
    3105232
  • 财政年份:
    1993
  • 资助金额:
    $ 29.8万
  • 项目类别:
SCOR IN SYSTEMIC LUPUS ERTHEMATOSUS
系统性红斑狼疮的 SCOR
  • 批准号:
    3105231
  • 财政年份:
    1993
  • 资助金额:
    $ 29.8万
  • 项目类别:
SCOR IN SYSTEMIC LUPUS ERTHEMATOSUS
系统性红斑狼疮的 SCOR
  • 批准号:
    2081931
  • 财政年份:
    1993
  • 资助金额:
    $ 29.8万
  • 项目类别:
B CELLS IN MURINE SLE
小鼠 SLE 中的 B 细胞
  • 批准号:
    3161069
  • 财政年份:
    1990
  • 资助金额:
    $ 29.8万
  • 项目类别:
B CELLS IN MURINE SLE
小鼠 SLE 中的 B 细胞
  • 批准号:
    2080169
  • 财政年份:
    1990
  • 资助金额:
    $ 29.8万
  • 项目类别:
B CELLS IN MURINE SLE
小鼠 SLE 中的 B 细胞
  • 批准号:
    3161070
  • 财政年份:
    1990
  • 资助金额:
    $ 29.8万
  • 项目类别:
B CELLS IN MURINE SLE
小鼠 SLE 中的 B 细胞
  • 批准号:
    2683290
  • 财政年份:
    1990
  • 资助金额:
    $ 29.8万
  • 项目类别:

相似海外基金

MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
  • 批准号:
    10618790
  • 财政年份:
    2021
  • 资助金额:
    $ 29.8万
  • 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
  • 批准号:
    10392325
  • 财政年份:
    2021
  • 资助金额:
    $ 29.8万
  • 项目类别:
MHC Class II Antigen Presentation In Melanoma: Impact on Immune Recognition
黑色素瘤中 MHC II 类抗原的呈现:对免疫识别的影响
  • 批准号:
    10674177
  • 财政年份:
    2021
  • 资助金额:
    $ 29.8万
  • 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
  • 批准号:
    8360306
  • 财政年份:
    2011
  • 资助金额:
    $ 29.8万
  • 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
  • 批准号:
    8167705
  • 财政年份:
    2010
  • 资助金额:
    $ 29.8万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    8131116
  • 财政年份:
    2007
  • 资助金额:
    $ 29.8万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7321929
  • 财政年份:
    2007
  • 资助金额:
    $ 29.8万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7673392
  • 财政年份:
    2007
  • 资助金额:
    $ 29.8万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7483748
  • 财政年份:
    2007
  • 资助金额:
    $ 29.8万
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7907767
  • 财政年份:
    2007
  • 资助金额:
    $ 29.8万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了